(*contributed equally to this work) 发布: 2017年05月20日第7卷第10期 DOI: 10.21769/BioProtoc.2299 浏览次数: 14814
评审: Renate WeizbauerJingyu PengAnonymous reviewer(s)
相关实验方案
在哺乳动物细胞中通过具有 3' 突出端的长 dsDNA 介导的 CRISPR 敲入 (LOCK) 实现高效的大 DNA 片段敲入
Wenjie Han [...] Jianqiang Bao
2023年10月20日 1768 阅读
Abstract
To achieve the C-terminal tagging of endogenous proteins in T. cruzi we use the Cas9/pTREX-n vector (Lander et al., 2015) to insert a specific tag sequence (3xHA or 3xc-Myc) at the 3’ end of a specific gene of interest (GOI). Chimeric sgRNA targeting the 3’ end of the GOI is PCR-amplified and cloned into Cas9/pTREX-n vector. Then a DNA donor molecule to induce DNA repair by homologous recombination is amplified. This donor sequence contains the tag sequence and a marker for antibiotic resistance, plus 100 bp homology arms corresponding to regions located right upstream of the stop codon and downstream of the Cas9 target site at the GOI locus. Vectors pMOTag23M (Oberholzer et al., 2006) or pMOHX1Tag4H (Lander et al., 2016b) are used as PCR templates for DNA donor amplification. Epimastigotes co-transfected with the sgRNA/Cas9/pTREX-n construct and the DNA donor cassette are then cultured for 5 weeks with antibiotics for selection of double resistant parasites. Endogenous gene tagging is finally verified by PCR and Western blot analysis.
Keywords: CRISPR/Cas9 (CRISPR/Cas9)Background
Genetic manipulation of protist parasites has significantly increased since the emergence of the CRISPR/Cas9 technology (Lander et al., 2016a). Trypanosoma cruzi is the causative agent of Chagas disease, which affects millions of people worldwide, particularly in Central and South America where the disease is endemic. Vaccines to prevent this disease have not been developed, and available drug treatments are not completely effective (Urbina and Docampo, 2003). This parasite has been particularly refractory to genetic manipulation (Docampo, 2011). However, the recent use of the CRISPR/Cas9 technology for gene knockout and knockdown (Peng et al., 2014; Lander et al., 2015) and to perform endogenous gene tagging (Lander et al., 2016b) has transformed the approaches for functional study of proteins in this organism. Here we describe a protocol to generate CRISPR/Cas9-mediated endogenous gene tagging in T. cruzi, leading to the expression of specific C-terminal tagged proteins in this parasite. Tagged proteins can be detected by Western blot analysis and their subcellular localization can be determined by immunofluorescence microscopy. Other potential applications of the technique include immunoprecipitation assays and tandem affinity purification (TAP) to establish protein-protein interactions.
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2017 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
分类
免疫学 > 宿主防御 > 综合
分子生物学 > DNA > DNA 修饰
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link